H 643 – North Carolina

Status: Inactive / Dead
Year Introduced: 2021
Link: https://www.ncleg.gov/BillLookUp/2021/H643

Reference Pricing for Rx Drugs. Establishes an annual process beginning in 2022 for determining the referenced rate, defined as the maximum rate established by the Commissioner of Insurance using the Wholesale Acquisition Cost and other pricing data, for referenced drugs, which are 250 of the most costly prescription drugs for members of the State Health Plan for Teachers and State Employees (SHP) for a particular calendar year.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found